Corporate Profile

AtriCure was formed by a team with extensive experience in the medical device industry. The company is focused on developing innovative products using proprietary technology that provides doctors alternative, expedient methods to ablate tissue during surgical procedures.

Recent News

DateTitle 
11/24/08AtriCure to Present at the Piper Jaffray Health Care Conference
WEST CHESTER, Ohio, Nov 24, 2008 (BUSINESS WIRE) -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that David J. Drachman, President and Chief Executive Officer, will present at the 20th Annual Piper Jaffray Health Care Conference at the New York Palace Hotel in New York City on Wednesday, December 3, 2008 at 11:30 a.m. Eastern Time. A live audio webcast and replay of the presenta... 
Printer Friendly Version
11/04/08AtriCure Reports Strong Third Quarter 2008 Financial Results
3rd Quarter Highlights Consolidated revenues of $14.8 million - 23% growth Record revenues for domestic MIS of $5.7 million - 63% growth Record international revenues of $2.4 million - 29% growth Net loss improves 32% to $1.8 million Initiated EXCLUDE clinical trial WEST CHESTER, Ohio--(BUSINESS WIRE)--Nov. 4, 2008--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, ... 
Printer Friendly Version
10/31/08AtriCure Announces Investigation by the Department of Justice
WEST CHESTER, Ohio--(BUSINESS WIRE)--Oct. 31, 2008--AtriCure, Inc. (Nasdaq: ATRC), received a letter on October 27, 2008 from the U.S. Department of Justice-Civil Division (the "DOJ") informing the Company that the DOJ is conducting an investigation for potential False Claims Act and common law violations relating to the Company's surgical ablation devices. Specifically, the letter states that the DOJ is investigating the Company's marketing practices utilized in connection with its s... 
Printer Friendly Version
10/06/08AtriCure Announces Web Cast and Conference Call of Third Quarter 2008 Financial Results
WEST CHESTER, Ohio, Oct. 6 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, will release its financial results for the third quarter ended September 30, 2008 on Tuesday, November 4, 2008. AtriCure will host a conference call at 10:00 a.m. Eastern Time on Tuesday, November 4, 2008 to discuss its third quarter 2008 financial results. A live web cast of the conference call will be available online fro... 
Printer Friendly Version
  More News >>

Company Calendar

January 2009?
Today
SunMonTueWedThuFriSat
-4-3-2-1123
45678910
11121314151617
18192021222324
25262728293031
ATRC (Common)
ExchangeNASDAQ (US Dollar)
Price$2.15
Change (%) Stock is Down 0.05 (2.27%)
Volume134,354
Data as of 01/05/09
3:33 p.m. ET
Minimum 20 minute delay
Refresh quote

Featured Report

Download Documentation 2007 Annual Report
Investor Tools
Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.